Results 191 to 200 of about 163,161 (264)

Prognostic significance of the CRP-albumin-lymphocyte (CALLY) index in esophageal cancer: systematic review and meta-analysis. [PDF]

PeerJ
Xu W, Zhan D, Wang R, Jin S, Liu XB.
europepmc   +1 more source

Emerging research themes in macrophage-associated research for esophageal cancer: a bibliometric and visualized analysis. [PDF]

J Thorac Dis
Chen Y, Yang M.
europepmc   +1 more source

Preoperative Anemia and Perioperative Outcomes in Children: Prevalence, Risk Factors, and Associations in an Australian Cohort

Pediatric Anesthesia, EarlyView.
ABSTRACT Aims Preoperative anemia is a potentially modifiable risk factor in children undergoing surgery, but contemporary data describing its prevalence and associated outcomes in high‐income settings are limited. We aimed to determine the prevalence of anemia in a pediatric major‐surgery surgical cohort, identify associated demographic and clinical ...
Matthew Hart, Alexandra Batinic, Justin Skowno   +2 more
wiley   +1 more source

Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights

The Journal of Pathology, EarlyView.
Abstract Tumor border configuration influences colorectal cancer (CRC) prognosis, yet its molecular determinants remain unclear and existing assessment criteria have faced challenges with reproducibility. We introduce the Tumor Invasive Border Index (TIBI), a novel and reproducible method that quantifies the proportion of tumor stroma and adipose ...
Akseli Kehusmaa, Jouni Härkönen, Huayi Li, Päivi Sirniö, Ville K Äijälä, Henna Karjalainen, Meeri Kastinen, Vilja V Tapiainen, Tuomo Mantere, Vesa‐Matti Pohjanen, Hanna Elomaa, Onni Sirkiä, Nicolas Pasquier, Maarit Ahtiainen, Olli Helminen, Erkki‐Ville Wirta, Taneli T Mattila, Outi Lindgren, Janette Savela, Jukka Rintala, Sanna Meriläinen, Juha Saarnio, Tero Rautio, Toni T Seppälä, Jan Böhm, Jukka‐Pekka Mecklin, Markus J Mäkinen, Anne Tuomisto, Johanna Ivaska, Juha P Väyrynen   +29 more
wiley   +1 more source

Organ preservation in esophageal cancer treatment, is it time now? [PDF]

World J Gastroenterol
Xu JH, Liu Y.
europepmc   +1 more source

The characterization of dysphagia in COVID‐19 rehabilitation patients: An inpatient rehabilitation cohort study

PM&R, EarlyView.
Abstract Background Severe COVID‐19 infection requiring hospitalization is associated with oropharyngeal dysphagia, yet trajectories in the inpatient rehabilitation facility (IRF) setting remain undercharacterized. Objective To investigate the prevalence, risk factors, recovery likelihood, and evolution of dietary requirements of patients with ...
Benjamin K. Petrie, Christopher W. Lewis, Sean Dreyer, Prakash Jayabalan   +3 more
wiley   +1 more source

USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer. [PDF]

Cell Death Dis
Zhao K, Zhang L, Yan M, Fang S, Wang Z, Song Y, Liu M, Zhang C, Shao Y, Jia X, Guo Q, Guo M, Yin J, Jin G, Dong Z.   +14 more
europepmc   +1 more source

A Case of Ileal Conduit Bleeding Caused by Porto‐Sinusoidal Vascular Disorder

Portal Hypertension &Cirrhosis, EarlyView.
ABSTRACT A 60‐year‐old man presented with recurrent stomal bleeding for 3 years. He had undergone cystoprostatectomy with ileal conduit diversion for bladder cancer 7 years prior. Endoscopy revealed multiple protruding lesions (0.6–0.8 cm) inside the stoma, which were initially suspected to be ectopic varices given concomitant esophageal varices and ...
Lu Yu, Hao Wu, Huan Tong
wiley   +1 more source

Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer. [PDF]

J Immunother Cancer
Yu Z, Li W, Xu S, Xu M, Lin Q, Liu L, Zhang J, Zhong X, Jin C, Zuo L, Cai R, Wang M, Huang H, Zhu X, Riaz M, Suo S, Zhou M, Zheng Y.   +17 more
europepmc   +1 more source

Nanoparticle polymeric micellar paclitaxel compared with paclitaxel for advanced esophageal squamous cell carcinoma

Precision Medical Sciences, EarlyView.
The nanoparticle polymeric micellar paclitaxel plus nedaplatin regimen demonstrates superior efficacy and tolerable toxicities compared to the paclitaxel–nedaplatin combination as a first‐line treatment for advanced esophageal squamous cell carcinoma.
Yu‐Qing Cao, Meng Song, Bing‐jie Xue, Fei‐Yu Wang, Xiang‐Ming Huang, Jie Cao, Ai‐Guo Cao, Xin‐En Huang   +7 more
wiley   +1 more source